Applying PBM Techniques To Medicare "Would Be Difficult," GAO Testifies
Executive Summary
Pharmacy benefit management techniques may be incompatible with Medicare's need for transparency and equity for beneficiaries, according to the General Accounting Office.
You may also be interested in...
PBMs Must Use "Aggressive" Rx Cost Containment In Medicare - Rep. Thomas
Discussions about the structure of competition under a pharmacy benefit management company administered Medicare drug benefit are irrelevant if PBMs are not able to pursue "aggressive" cost containment, House Ways & Means/Health Subcommittee Chairman Thomas (R-Calif.) said during a May 11 hearing.
PBMs Must Use "Aggressive" Rx Cost Containment In Medicare - Rep. Thomas
Discussions about the structure of competition under a pharmacy benefit management company administered Medicare drug benefit are irrelevant if PBMs are not able to pursue "aggressive" cost containment, House Ways & Means/Health Subcommittee Chairman Thomas (R-Calif.) said during a May 11 hearing.
Medicare+Choice Formulary Problems To Be Aired By Senate Aging Cmte.
Prescription drug formularies for seniors - a centerpiece of the Clinton Administration's Medicare drug benefit plan - will be in the spotlight at a July 20 hearing before the Senate Special Committee on Aging when the panel examines the effects of formulary changes on Medicare+Choice participants.